Skip to content
    Real-World Studies

    JCM, Vol. 15, Pages 7353: The Comparative Prognostic Value of the Interim PET Deauville Score and ΔSUVmax in Classical Hodgkin Lymphoma: A Real-World Study of Imaging and Inflammatory Markers

    Mersin et alJournal of Clinical Medicine

    In classical Hodgkin lymphoma (cHL), interim [18F]FDG-PET/CT evaluated by the Deauville score (DS) represents the standard for therapeutic response assessment. While quantitative metrics such as the relative reduction in maximum standardized uptake value (ΔSUVmax) and systemic inflammatory markers like the lymphocyte-to-monocyte ratio (LMR) have been proposed to refine interim risk assessment, their added prognostic utility and the reproducibility of published ΔSUVmax cutoffs have remained inconsistent across clinical cohorts.
    In a retrospective real-world study of 78 adult patients with cHL who underwent paired baseline and interim PET/CT scans, investigators assessed the comparative prognostic performance of the DS, published ΔSUVmax cutoffs, LMR, and the International Prognostic Score (IPS) for progression-free survival (PFS). Over a median follow-up of 47 months, 26 PFS events were observed. Analysis demonstrated that published high ΔSUVmax cutoffs between 83% and 88% failed to separate PFS curves, whereas a 66% cutoff demonstrated separation; nevertheless, ΔSUVmax provided no incremental prognostic benefit over the standard visual Deauville score.
    Interim DS positivity was significantly associated with worse PFS (HR 2.26, p = 0.040). Although lower baseline LMR independently improved risk prediction when combined with the DS (HR 0.45, p = 0.006), it correlated moderately with the IPS (rho = -0.51) without providing superior discrimination. Ultimately, integrating the interim DS with the baseline IPS demonstrated the highest prognostic accuracy (Harrell's C-index of 0.73 vs. 0.66 for DS-plus-LMR), cleanly distinguishing three risk groups with distinct 5-year PFS rates of 83%, 60%, and 24%. These findings indicate that published quantitative ΔSUVmax cutoffs lack reproducibility and that combining visual DS response with the established IPS offers a practical, low-cost risk stratification model.

    Key Takeaways

    • Interim Deauville score positivity significantly predicted inferior progression-free survival (HR 2.26, p = 0.040), whereas adding quantitative ΔSUVmax provided no incremental prognostic value and published cutoffs of 83% to 88% failed to stratify PFS.
    • Combining the Deauville score with the International Prognostic Score (IPS) effectively stratified patients into three risk groups with 5-year PFS rates of 83%, 60%, and 24%, outperforming a Deauville score plus lymphocyte-to-monocyte ratio model (C-index 0.73 vs. 0.66).
    Read the original sourceJournal of Clinical Medicine